ab109250 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab109250 は 7 報の論文で使用されています。

  • Yang Y  et al. Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure. Proc Natl Acad Sci U S A 112:E2337-46 (2015). PubMed: 25870291
  • Lee K  et al. Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. Proc Natl Acad Sci U S A 111:7260-5 (2014). ICC/IF ; Human . PubMed: 24799706
  • Zheng FM  et al. A novel small molecule aurora kinase inhibitor attenuates breast tumor-initiating cells and overcomes drug resistance. Mol Cancer Ther 13:1991-2003 (2014). PubMed: 24899685
  • Chlon TM  et al. High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells. J Virol 88:11315-26 (2014). PubMed: 25031356
  • Wu CP  et al. Identification of cancer stem-like side population cells in purified primary cultured human laryngeal squamous cell carcinoma epithelia. PLoS One 8:e65750 (2013). WB ; Human . PubMed: 23776540
  • Liu H  et al. Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cells. Cell Death Dis 4:e857 (2013). Flow Cyt ; Human . PubMed: 24136221
  • Yang CF  et al. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway. Cancer Lett N/A:N/A (2013). PubMed: 24262659

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"